SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech - Quaterly Results

30 May 2025 Evaluate
The sales moved down -42.24% to Rs. 259.95 millions for the March 2025 quarter as compared to Rs. 450.07 millions during the corresponding quarter last year.Net profit declined -22.33% to Rs. 24.10 millions from Rs. 31.03 millions.Operating profit for the quarter ended March 2025 decreased to 41.26 millions as compared to 73.65 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 259.95 450.07 -42.24 1514.63 1723.86 -12.14 1514.63 1723.86 -12.14
Other Income 52.20 5.43 861.33 62.25 23.03 170.30 62.25 23.03 170.30
PBIDT 41.26 73.65 -43.98 227.83 282.74 -19.42 227.83 282.74 -19.42
Interest 6.23 18.67 -66.63 30.45 43.77 -30.43 30.45 43.77 -30.43
PBDT 35.03 54.98 -36.29 197.38 238.97 -17.40 197.38 238.97 -17.40
Depreciation 4.66 17.73 -73.72 69.53 70.08 -0.78 69.53 70.08 -0.78
PBT 30.37 37.25 -18.47 127.85 168.89 -24.30 127.85 168.89 -24.30
TAX 6.27 6.22 0.80 33.24 35.90 -7.41 33.24 35.90 -7.41
Deferred Tax -0.99 -1.69 -41.42 -3.15 -6.27 -49.76 -3.15 -6.27 -49.76
PAT 24.10 31.03 -22.33 94.61 132.99 -28.86 94.61 132.99 -28.86
Equity 127.15 127.15 0.00 127.15 127.15 0.00 127.15 127.15 0.00
PBIDTM(%) 15.87 16.36 -3.01 15.04 16.40 -8.29 15.04 16.40 -8.29

Medicamen Biotech Share Price

242.25 -0.20 (-0.08%)
13-Apr-2026 12:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.95
Dr. Reddys Lab 1223.60
Cipla 1213.85
Zydus Lifesciences 923.70
Lupin 2320.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×